2023 Press Releases

Cogent Bioscience

COGENT BIOSCIENCES ANNOUNCES POSITIVE DATA FROM ONGOING PHASE 2 APEX TRIAL EVALUATING BEZUCLASTINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)
December 11, 2023

Cogent Bioscience

COGENT BIOSCIENCES ANNOUNCES POSITIVE INITIAL DATA FROM PHASE 2 SUMMIT TRIAL EVALUATING BEZUCLASTINIB IN PATIENTS WITH NONADVANCED SYSTEMIC MASTOCYTOSIS (NONADVSM)
December 9, 2023

Cogent Bioscience

COGENT BIOSCIENCES PRESENTS NEW PRECLINICAL DATA HIGHLIGHTING POTENTIAL BEST-IN-CLASS POTENCY AND SELECTIVITY OF ERBB2 AND PI3KΑ INHIBITOR PROGRAMS AT THE SAN ANTONIO BREAST CANCER SYMPOSIUM
December 7, 2023

Arvinas logo

Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) and Plans to Expand Vepdegestrant Development Programt
December 5, 2023

Arvinas logo

Arvinas Announces Oversubscribed $350 Million Private Placement
November 27, 2023

Cleerly logo

Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at AHA 2023
November 11, 2023

BlueSight

Bluesight Appoints Jason Vander Meer as Chief Product Officer to Expand Medication Intelligence Suite
October 26, 2023

Harpoon Therapeutics logo

HARPOON THERAPEUTICS ANNOUNCES UP TO $150 MILLION PRIVATE PLACEMENT
October 23, 2023

Kalderos

Kalderos Adds Powerful Features to Commercial Drug Discount Monitoring Solution
September 23, 2023

Kalderos

Kalderos names veteran healthcare leader Angie Franks as new CEO
September 20, 2023

Deciphera logo

Deciphera Pharmaceuticals Announces Positive Top-line Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) and Updated Results from Phase 1/2 Study of Vimseltinib in TGCT
October 30, 2023

Abcuro

Abcuro Announces $155 Million Oversubscribed Series B Financing to Further Advance Autoimmune Pipeline
August 17, 2023

 

Lilly Completes Acquisition of DICE Therapeutics
August 9, 2023

Passage Bio

PASSAGE BIO ANNOUNCES PROMISING INTERIM CLINICAL DATA FROM FIRST EIGHT PATIENTS WITH GM1 GANGLIOSIDOSIS IN IMAGINE-1 STUDY
August 7, 2023

BlueSight

Thoma Bravo Announces Strategic Growth Investment in Bluesight to Support the Company’s Acquisition of Medacist
July 17, 2023

Harpoon Therapeutics logo

HARPOON THERAPEUTICS ANNOUNCES COMPLETION OF PLANNED PATIENT ENROLLMENT IN PHASE 1 STUDY OF HPN217 IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
June 27, 2023

Edgewise

Edgewise Therapeutics Announces Positive 12-Month Topline Results From The ARCH Open Label Study Of EDG-5506 In Adults With Becker Muscular Dystrophy (BMD)
June 26, 2023

Kyruus logo

Silver Cross Hospital Expands Use of Kyruus’ Award-Winning Online Scheduling Solution Across Specialties and Services
June 20, 2023

 

Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
June 20, 2023

Arvinas logo

Arvinas Announces Interim Data from the ARV-766 Phase 1/2 Dose Escalation and Expansion Trial Showing Promising Signals of Efficacy in Late-line mCRPC, Including in Patients with AR L702H Mutations
June 8, 2023

Cogent Bioscience

COGENT BIOSCIENCES ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF SHARES OF COMMON STOCK
June 6, 2023

Cogent Bioscience

COGENT BIOSCIENCES ANNOUNCES POSITIVE LEAD-IN DATA FROM ONGOING PHASE 3 PEAK TRIAL EVALUATING BEZUCLASTINIB IN COMBINATION WITH SUNITINIB IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
June 3, 2023

Cleerly logo

Cleerly Partners with ProScan Imaging to Transform the Standard of Care for Heart Disease Prevention
June 1, 2023

Vega Therapeutics Receives FDA Orphan Drug Designation for VGA039 for the Treatment of von Willebrand Disease
May 23, 2023

BlueSight

CostCheck From Bluesight Wins 2023 MedTech Breakthrough Award
May 10, 2023

Arvinas logo

Arvinas and Quantum Leap Healthcare Announce Clinical Study to Evaluate Vepdegestrant (ARV-471) in I-SPY-2 Endocrine Optimization Platform (EOP) Clinical Trial
May 2, 2023

Cogent Bioscience

COGENT BIOSCIENCES PRESENTS PRECLINICAL DATA AT AACR ANNUAL MEETING HIGHLIGHTING PRECISION THERAPY PIPELINE AND ANNOUNCES INITIATION OF PART 2 OF THE REGISTRATION-ENABLING APEX TRIAL WITH BEZUCLASTINIB IN ADVANCED SYSTEMIC MASTOCYTOSIS
April 17, 2023

RallyBio

Thrombocytopenia (FNAIT), Published in the Journal of Thrombosis and Haemostasis
April 6, 2023

Kyruus logo

Intermountain Health Expands Relationship with Kyruus to Create Foundation for Rebranded Digital Experience
April 5, 2023

RallyBio

Rallybio Announces Acceptance of Abstract for RLYB212 at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH)
April 3, 2023

TigerConnect

TigerConnectAppoints Two SaaS Leaders to Drive Product Enhancements and Revenue Growth
March 24, 2023

Brightinsight logo

BrightInsight Named to Fierce Medtech’s 2022 Fierce 15 List
March 20, 2023

Deciphera logo

Deciphera Pharmaceuticals Announces QINLOCK® Included in NCCN Guidelines® for the Treatment of Second-Line GIST Patients and FDA Grants Breakthrough Therapy Designation for QINLOCK in Second-Line GIST Patients with Mutations in KIT Exon 11 and 17/18
March 14, 2023

RallyBio

Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
March 6, 2023

Kalderos

Deciphera Pharmaceuticals Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session
January 24, 2023

Brightinsight logo

BrightInsight Welcomes ixlayer to the BrightInsight Ecosystem to Streamline Diagnosis and Improve Therapy Matching
February 22, 2023

Deciphera logo

Deciphera Pharmaceuticals Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session
January 24, 2023

Deciphera logo

Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 24, 2023

Kyruus logo

Kyruus Reports Landmark Year, Cementing Position as a Foundational Digital Health Platform
January 9, 2023